IRIS Accounts Production v23.3.0.418 09022475 Board of Directors Board of Directors 1.6.22 31.5.23 31.5.23 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh090224752022-05-31090224752023-05-31090224752022-06-012023-05-31090224752021-05-31090224752021-06-012022-05-31090224752022-05-3109022475ns10:Originalns15:EnglandWales2022-06-012023-05-3109022475ns14:PoundSterlingns10:Original2022-06-012023-05-3109022475ns10:Originalns10:Director12022-06-012023-05-3109022475ns10:Original2022-06-012023-05-3109022475ns10:Originalns10:Director22022-06-012023-05-3109022475ns10:Original2023-05-3109022475ns10:Originalns10:PrivateLimitedCompanyLtd2022-06-012023-05-3109022475ns10:Originalns10:SmallEntities2022-06-012023-05-3109022475ns10:Originalns10:AuditExempt-NoAccountantsReport2022-06-012023-05-3109022475ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-06-012023-05-3109022475ns10:SmallCompaniesRegimeForAccountsns10:Original2022-06-012023-05-3109022475ns10:Originalns10:FullAccounts2022-06-012023-05-3109022475ns10:Originalns10:OrdinaryShareClass12022-06-012023-05-3109022475ns10:CompanySecretary1ns10:Original2022-06-012023-05-3109022475ns10:Originalns10:RegisteredOffice2022-06-012023-05-3109022475ns10:Original2022-05-3109022475ns10:Originalns5:CurrentFinancialInstruments2023-05-3109022475ns10:Originalns5:CurrentFinancialInstruments2022-05-3109022475ns10:Originalns5:Non-currentFinancialInstruments2023-05-3109022475ns10:Originalns5:Non-currentFinancialInstruments2022-05-3109022475ns5:ShareCapitalns10:Original2023-05-3109022475ns5:ShareCapitalns10:Original2022-05-3109022475ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-05-3109022475ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-05-3109022475ns10:Original2021-06-012022-05-3109022475ns10:Originalns5:LandBuildings2022-05-3109022475ns10:Originalns5:LandBuildings2023-05-3109022475ns10:Originalns5:LandBuildings2022-05-3109022475ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-05-3109022475ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-05-3109022475ns10:Originalns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2023-05-3109022475ns10:Originalns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2022-05-3109022475ns10:Originalns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-05-3109022475ns10:Originalns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2022-05-3109022475ns10:Originalns10:OrdinaryShareClass12023-05-3109022475ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-05-3109022475ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-06-012023-05-31
REGISTERED NUMBER: 09022475 (England and Wales)










Unaudited Financial Statements

for the Year Ended 31 May 2023

for

The Gables Surgery Limited

The Gables Surgery Limited (Registered number: 09022475)






Contents of the Financial Statements
for the Year Ended 31 May 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


The Gables Surgery Limited

Company Information
for the Year Ended 31 May 2023







DIRECTORS: Dr S M Chen
Dr G Kargwal





SECRETARY:





REGISTERED OFFICE: The Gables Surgery
Swinnow Green
Pudsey
Leeds
West Yorkshire
LS28 9AW





REGISTERED NUMBER: 09022475 (England and Wales)





ACCOUNTANTS: SKS Bailey Group Limited
Suite 4, 10/12 The Grove,
Ilkley
West Yorkshire
LS29 9EG

The Gables Surgery Limited (Registered number: 09022475)

Balance Sheet
31 May 2023

2023 2022
Notes £    £   
FIXED ASSETS
Tangible assets 3 1,210,515 1,210,515

CURRENT ASSETS
Cash at bank and in hand 89,303 99,870

CREDITORS
Amounts falling due within one year 4 (52,724 ) (62,038 )
NET CURRENT ASSETS 36,579 37,832
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,247,094

1,248,347

CREDITORS
Amounts falling due after more than one
year

5

(950,596

)

(978,821

)
NET ASSETS 296,498 269,526

CAPITAL AND RESERVES
Called up share capital 7 300 300
Retained earnings 8 296,198 269,226
SHAREHOLDERS' FUNDS 296,498 269,526

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The Gables Surgery Limited (Registered number: 09022475)

Balance Sheet - continued
31 May 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20 September 2023 and were signed on its behalf by:




Dr S M Chen - Director



Dr G Kargwal - Director


The Gables Surgery Limited (Registered number: 09022475)

Notes to the Financial Statements
for the Year Ended 31 May 2023

1. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TANGIBLE FIXED ASSETS
The tangible fixed asset consists of an investment property which is not subject to periodic charges for depreciation. The property is stated at cost as the directors do not consider it appropriate to revalue the asset each year.

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

2. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

3. TANGIBLE FIXED ASSETS
Freehold
property
£   
COST
At 1 June 2022
and 31 May 2023 1,210,515
NET BOOK VALUE
At 31 May 2023 1,210,515
At 31 May 2022 1,210,515

The Gables Surgery Limited (Registered number: 09022475)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023

4. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts (see note 6) 35,066 41,338
Trade creditors 1,529 849
Corporation tax 9,142 12,698
VAT 394 559
Accrued expenses 6,593 6,594
52,724 62,038

5. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2023 2022
£    £   
Bank loans (see note 6) 950,596 978,821

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 803,239 795,918

6. LOANS

An analysis of the maturity of loans is given below:

2023 2022
£    £   
Amounts falling due within one year or on demand:
Bank loans 35,066 41,338

Amounts falling due between one and two years:
Bank loans - 1-2 years 36,100 44,992

Amounts falling due between two and five years:
Bank loans - 2-5 years 111,257 137,911

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 803,239 795,918

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
300 Ordinary £1 300 300

The Gables Surgery Limited (Registered number: 09022475)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023

8. RESERVES
Retained
earnings
£   

At 1 June 2022 269,226
Profit for the year 38,972
Dividends (12,000 )
At 31 May 2023 296,198

9. ULTIMATE CONTROLLING PARTY

The controlling party is Dr S Chen and Dr G Kargwal..